Cellyan Biotechnology (HKPD) Other financing activities (2024)

Cellyan Biotechnology (HKPD) reported Other financing activities of -$50000.0 for Q3 2024, up 83.33% quarter-over-quarter from -$300000.0 in Q1 2024.

Cellyan Biotechnology (HKPD) Other financing activities (2024) Analysis & Trends

Cellyan Biotechnology (HKPD) has 1 years of Other financing activities data on file, last reported at -$50000.0 in Q3 2024.

Other financing activities for Q3 2024 came in at -$50000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was -$50000.0 (changed N/A YoY), and the FY2024 annual result was -$300000.0, changed N/A from the prior year.
Other financing activities climbed to -$50000.0 in Q3 2024 per HKPD's latest filing, from -$300000.0 in the prior quarter.
Over five years, Other financing activities peaked at -$50000.0 in Q3 2024 and troughed at -$300000.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Akso Health	2,315,158.81 Bn	2,315,158.63 Bn	-
2	Mckesson	92.76 Bn	89.18 Bn	4.04 Bn
3	Cencora	52.82 Bn	50.83 Bn	3.59 Bn
4	Cardinal Health	52.17 Bn	48.39 Bn	2.50 Bn
5	Henry Schein	9.19 Bn	9.71 Bn	1.07 Bn
6	Accendra Health	246.88 Mn	-90.00 Mn	312.39 Mn
7	Edap Tms	161.92 Mn	146.92 Mn	8.15 Mn
8	111	107.47 Mn	25.61 Mn	23.58 Mn
9	Cosmos Health	9.42 Mn	7.26 Mn	1.38 Mn
10	Cellyan Biotechnology	5.69	-2.48 Mn	-

Download Data